- Home
- ORMP vs FBIOP Comparison
ORMP vs FBIOP Comparison
Compare ORMP & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- FBIOP
- Stock Information
- Founded
- ORMP 2002
- FBIOP N/A
- Country
- ORMP United States
- FBIOP United States
- Employees
- ORMP N/A
- FBIOP 101
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- FBIOP Health Care
- Exchange
- ORMP Nasdaq
- FBIOP Nasdaq
- Market Cap
- ORMP N/A
- FBIOP N/A
- IPO Year
- ORMP N/A
- FBIOP N/A
- Fundamental
- Price
- ORMP $2.20
- FBIOP $8.12
- Analyst Decision
- ORMP Hold
- FBIOP
- Analyst Count
- ORMP 1
- FBIOP 0
- Target Price
- ORMP N/A
- FBIOP N/A
- AVG Volume (30 Days)
- ORMP 77.2K
- FBIOP N/A
- Earning Date
- ORMP 08-15-2025
- FBIOP N/A
- Dividend Yield
- ORMP N/A
- FBIOP N/A
- EPS Growth
- ORMP N/A
- FBIOP N/A
- EPS
- ORMP N/A
- FBIOP N/A
- Revenue
- ORMP $2,000,000.00
- FBIOP N/A
- Revenue This Year
- ORMP N/A
- FBIOP N/A
- Revenue Next Year
- ORMP N/A
- FBIOP N/A
- P/E Ratio
- ORMP N/A
- FBIOP N/A
- Revenue Growth
- ORMP 196.74
- FBIOP N/A
- 52 Week Low
- ORMP $1.82
- FBIOP N/A
- 52 Week High
- ORMP $3.09
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- ORMP 49.72
- FBIOP 49.79
- Support Level
- ORMP $2.10
- FBIOP $7.37
- Resistance Level
- ORMP $2.25
- FBIOP $8.40
- Average True Range (ATR)
- ORMP 0.09
- FBIOP 0.63
- MACD
- ORMP 0.00
- FBIOP -0.12
- Stochastic Oscillator
- ORMP 63.16
- FBIOP 37.80
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.